Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage III Malignant Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00898183
What this trial is testing

S9431: Studying Genes and Immune Response in Tumor Samples From Patients With Locally Advanced or Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
SWOG Cancer Research Network 91
Testing effectiveness (Phase 2)UnknownNCT00128583
What this trial is testing

Vaccine Therapy in Treating Patients With Malignant Melanoma

Who this might be right for
Melanoma (Skin)
CancerVax Corporation
Early research (Phase 1)Active Not RecruitingNCT01303341
What this trial is testing

Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or Melanoma

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent MelanomaRefractory Malignant Solid Neoplasm+5 more
National Cancer Institute (NCI) 35
Early research (Phase 1)Study completedNCT01213732
What this trial is testing

Phase 1 Dose-finding Study of L19TNFα Plus Melphalan Using Isolated Inferior Limb Perfusion (ILP) in Subjects With Intransit Stage III/IV Melanoma

Who this might be right for
Patients With Intransit Stage III/IV Melanoma
Philogen S.p.A. 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT02910700
What this trial is testing

Nivolumab With Trametinib and Dabrafenib, or Encorafenib and Binimetinib in Treating Patients With BRAF Mutated Metastatic or Unresectable Stage III-IV Melanoma

Who this might be right for
Metastatic Malignant Neoplasm in the BrainMetastatic MelanomaStage III Cutaneous Melanoma AJCC v7+5 more
M.D. Anderson Cancer Center 52
Testing effectiveness (Phase 2)Study completedNCT07671495
What this trial is testing

Adjuvant Therapy of Skin Melanoma With Alpha Interferon and Naderin

Who this might be right for
Melanoma Stage IMelanoma Stage IIIMelanoma Stage II+1 more
MIPO Clinic 278
Early research (Phase 1)WithdrawnNCT01455103
What this trial is testing

Phase 1 Biomarker Study of Anti-PDL-1 in Advanced Melanoma

Who this might be right for
Stage III or IV Melanoma
Bristol-Myers Squibb
Not applicableLooking for participantsNCT05940311
What this trial is testing

Versatile Ampification Single-Molecule Detection in Liquid Biopsy

Who this might be right for
Liquid BiopsyMelanoma (Skin)Melanoma Stage III+1 more
Regina Elena Cancer Institute 20
Testing effectiveness (Phase 2)Study completedNCT00119249
What this trial is testing

Sorafenib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery

Who this might be right for
Stage III MelanomaStage IV Melanoma
National Cancer Institute (NCI) 74
Early research (Phase 1)Study completedNCT02318771
What this trial is testing

Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer

Who this might be right for
Head and Neck Squamous Cell CarcinomaMetastatic Renal Cell CancerRecurrent Head and Neck Carcinoma+6 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 41
Testing effectiveness (Phase 2)Ended earlyNCT01474551
What this trial is testing

Vemurafenib (R05185426) in Poor Performance Status Patients With Unresectable Locally Advanced or Metastatic Melanoma Harboring a V600E/K Mutation

Who this might be right for
Melanoma
Memorial Sloan Kettering Cancer Center 2
Large-scale testing (Phase 3)Study completedNCT00006237
What this trial is testing

S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma

Who this might be right for
Melanoma (Skin)
SWOG Cancer Research Network 432
Testing effectiveness (Phase 2)Study completedNCT02129075
What this trial is testing

A Vaccine (CDX-1401) With or Without a Biologic Drug (CDX-301) for the Treatment of Patients With Stage IIB-IV Melanoma

Who this might be right for
Cutaneous MelanomaMelanomaMelanoma of Unknown Primary+9 more
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT03153085
What this trial is testing

Combination with TBI-1401(HF10) and Ipilimumab in Japanese Patients with Unresectable or Metastatic Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
Takara Bio Inc. 28
Early research (Phase 1)Ended earlyNCT01045915
What this trial is testing

Safety and Efficacy Study of Electrotransfer of Plasmid AMEP to Treat Advanced or Metastatic Melanoma

Who this might be right for
Melanoma
Valerio Therapeutics 5
Testing effectiveness (Phase 2)Study completedNCT02155322
What this trial is testing

A Phase II Study of Pegylated Interferon Alfa-2b for the Adjuvant Treatment of Melanoma Subjects in Russia (MK-4031-400)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 33
Testing effectiveness (Phase 2)Study completedNCT01321437
What this trial is testing

Study of the Anti-Angiogenesis Agent Axitinib in Patients With Stage III Malignant Melanoma

Who this might be right for
MelanomaMalignant MelanomaStage IIIA Melanoma+2 more
University of California, Irvine 11
Early research (Phase 1)Study completedNCT00515983
What this trial is testing

Vaccination of Melanoma Patients With Dendritic Cells Loaded With Allogeneic Apoptotic-Necrotic Melanoma Cells

Who this might be right for
Melanoma
José Mordoh, M.D., Ph.D. 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT04079166
What this trial is testing

SCIB1 and iSCIB1+ in Melanoma Patients Receiving Nivolumab With Ipilimumab or SCIB1 With Pembrolizumab (The SCOPE Study)

Who this might be right for
Malignant MelanomaMelanoma (Skin)Melanoma Stage III+1 more
Scancell Ltd 173
Testing effectiveness (Phase 2)Active Not RecruitingNCT04305145
What this trial is testing

Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVSkin Cancer Stage III+4 more
Massachusetts General Hospital 42
Next Page